Related references
Note: Only part of the references are listed.Assessing the lipophilicity of fragments and early hits
Paul N. Mortenson et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2011)
Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)
Chris P. Carron et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
Prostaglandin H-2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2
Rufina Schuligoi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
The rise of fragment-based drug discovery
Christopher W. Murray et al.
NATURE CHEMISTRY (2009)
Novel prostaglandin D synthase inhibitors generated by fragment-based drug design
Morten Hohwy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Identification of inhibitors of protein kinase B using fragment-based lead discovery
Gordon Saxty et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
An integrated approach to fragment-based lead generation: Philosophy, strategy and case studies from AstraZeneca's drug discovery programmes
Jeffrey S. Albert et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Hematopoietic prostaglandin D synthase
Y Kanaoka et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
Pharmaceutical profiling in drug discovery
EH Kerns et al.
DRUG DISCOVERY TODAY (2003)
Share Paper
